Klépierre Valuation
Is LIP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LIP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: LIP (€28.21) is trading above our estimate of fair value (€16.39)
Significantly Below Fair Value: LIP is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LIP?
Key metric: As LIP is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is LIP's PE Ratio? | |
|---|---|
| PE Ratio | 12x |
| Earnings | €677.30m |
| Market Cap | €8.16b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 11x |
| Enterprise Value/EBITDA | 16.8x |
| PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does LIP's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 68.6x | ||
SHC Shaftesbury Capital | 65.6x | 28.4% | UK£2.5b |
NRR NewRiver REIT | 96.8x | 33.0% | UK£290.5m |
CAL Capital & Regional | 68.7x | 47.8% | UK£144.2m |
LAND Land Securities Group | 43.3x | 26.4% | UK£4.6b |
LIP Klépierre | 12x | 9.4% | €8.2b |
Price-To-Earnings vs Peers: LIP is good value based on its Price-To-Earnings Ratio (12x) compared to the peer average (68.6x).
Price to Earnings Ratio vs Industry
How does LIP's PE Ratio compare vs other companies in the European Retail REITs Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: LIP is good value based on its Price-To-Earnings Ratio (12x) compared to the European Retail REITs industry average (22.5x).
Price to Earnings Ratio vs Fair Ratio
What is LIP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 12x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate LIP's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €28.21 | €29.87 +5.9% | 10.3% | €34.00 | €23.00 | n/a | 15 |
| Nov ’25 | €29.45 | €29.73 +1.0% | 10.8% | €34.00 | €23.00 | n/a | 15 |
| Oct ’25 | €29.38 | €28.23 -3.9% | 10.9% | €32.50 | €23.00 | n/a | 15 |
| Sep ’25 | n/a | €27.05 0% | 15.2% | €33.70 | €21.00 | n/a | 15 |
| Aug ’25 | €26.58 | €27.05 +1.8% | 15.2% | €33.70 | €21.00 | n/a | 15 |
| Jul ’25 | €25.52 | €26.56 +4.1% | 15.0% | €33.40 | €21.00 | n/a | 15 |
| Jun ’25 | €26.48 | €24.67 -6.8% | 17.2% | €32.00 | €14.60 | n/a | 15 |
| May ’25 | n/a | €24.63 0% | 16.9% | €32.00 | €14.60 | n/a | 15 |
| Apr ’25 | n/a | €24.36 0% | 16.7% | €32.00 | €14.60 | n/a | 15 |
| Mar ’25 | €23.45 | €24.11 +2.8% | 17.5% | €31.80 | €14.60 | n/a | 15 |
| Feb ’25 | €24.13 | €24.01 -0.5% | 17.4% | €31.40 | €14.60 | n/a | 15 |
| Jan ’25 | €24.83 | €23.01 -7.3% | 18.7% | €30.10 | €14.60 | n/a | 15 |
| Dec ’24 | €23.39 | €22.93 -2.0% | 19.2% | €30.40 | €14.60 | n/a | 15 |
| Nov ’24 | n/a | €22.99 0% | 19.4% | €30.40 | €14.60 | €29.45 | 15 |
| Oct ’24 | €23.54 | €22.54 -4.2% | 19.4% | €29.20 | €14.60 | €29.38 | 16 |
| Sep ’24 | n/a | €22.09 0% | 21.7% | €29.20 | €12.30 | n/a | 16 |
| Aug ’24 | €23.99 | €22.01 -8.3% | 21.4% | €28.40 | €12.30 | €26.58 | 16 |
| Jul ’24 | €22.72 | €21.69 -4.5% | 20.9% | €28.40 | €12.30 | €25.52 | 16 |
| Jun ’24 | €21.09 | €21.63 +2.5% | 20.6% | €28.00 | €12.30 | €26.48 | 16 |
| May ’24 | €23.22 | €21.73 -6.4% | 21.4% | €28.00 | €12.30 | n/a | 15 |
| Apr ’24 | €20.81 | €21.12 +1.5% | 22.3% | €28.00 | €12.30 | n/a | 15 |
| Mar ’24 | €23.88 | €21.47 -10.1% | 24.5% | €31.00 | €12.30 | €23.45 | 15 |
| Feb ’24 | €23.09 | €21.39 -7.3% | 24.2% | €31.00 | €12.30 | €24.13 | 15 |
| Jan ’24 | €22.04 | €21.20 -3.8% | 22.8% | €31.00 | €12.30 | €24.83 | 15 |
| Dec ’23 | €21.91 | €20.73 -5.4% | 22.4% | €31.00 | €12.30 | €23.39 | 15 |
| Nov ’23 | €20.63 | €20.61 -0.08% | 22.3% | €31.00 | €12.30 | n/a | 15 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Big Yellow Group
UK£2.2b
Big Yellow is the UK's brand leader in self storage.
BYG
UK£11.04
7D
-4.3%
1Y
0.9%
Immobiliare Grande Distribuzione SIIQ
€251.6m
Immobiliare Grande Distribuzione SIIQ S.p.A.
0STP
€2.25
7D
3.8%
1Y
2.7%
Care REIT
UK£359.3m
Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.
CRT
UK£0.87
7D
5.7%
1Y
1.0%